These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 14757160)

  • 1. Site-directed mutagenesis at the human B2 receptor and molecular modelling to define the pharmacophore of non-peptide bradykinin receptor antagonists.
    Meini S; Cucchi P; Bellucci F; Catalani C; Faiella A; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Biochem Pharmacol; 2004 Feb; 67(4):601-9. PubMed ID: 14757160
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A different molecular interaction of bradykinin and the synthetic agonist FR190997 with the human B2 receptor: evidence from mutational analysis.
    Bellucci F; Meini S; Cucchi P; Catalani C; Reichert W; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Br J Pharmacol; 2003 Oct; 140(3):500-6. PubMed ID: 12970081
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preliminary mutational analysis of the human kinin B2 receptor for nonpeptide antagonist ligands recognition.
    Meini S; Cucchi P; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Can J Physiol Pharmacol; 2002 Apr; 80(4):303-9. PubMed ID: 12025965
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MEN16132, a novel potent and selective nonpeptide antagonist for the human bradykinin B2 receptor. In vitro pharmacology and molecular characterization.
    Cucchi P; Meini S; Bressan A; Catalani C; Bellucci F; Santicioli P; Lecci A; Faiella A; Rotondaro L; Giuliani S; Giolitti A; Quartara L; Maggi CA
    Eur J Pharmacol; 2005 Dec; 528(1-3):7-16. PubMed ID: 16324696
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The N-terminal of icatibant and bradykinin interact with the same Asp residues in the human B2 receptor.
    Bellucci F; Meini S; Cucchi P; Catalani C; Giuliani S; Zappitelli S; Rotondaro L; Quartara L; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 May; 491(2-3):121-5. PubMed ID: 15140628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Peptide and non-peptide bradykinin B2 receptor agonists and antagonists: a reappraisal of their pharmacology in the guinea-pig ileum.
    Meini S; Patacchini R; Lecci A; Quartara L; Maggi CA
    Eur J Pharmacol; 2000 Dec; 409(2):185-94. PubMed ID: 11104833
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacological characterization of the bradykinin B2 receptor: inter-species variability and dissociation between binding and functional responses.
    Paquet JL; Luccarini JM; Fouchet C; Defrêne E; Loillier B; Robert C; Bélichard P; Cremers B; Pruneau D
    Br J Pharmacol; 1999 Mar; 126(5):1083-90. PubMed ID: 10204994
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MEN 11270, A novel selective constrained peptide antagonist with high affinity at the human B2 kinin receptor.
    Meini S; Quartara L; Rizzi A; Patacchini R; Cucchi P; Giolitti A; Calò G; Regoli D; Criscuoli M; Maggi CA
    J Pharmacol Exp Ther; 1999 Jun; 289(3):1250-6. PubMed ID: 10336513
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the molecular interactions of two antagonists, MEN16132 or icatibant, at the human kinin B₂ receptor.
    Meini S; Bellucci F; Catalani C; Cucchi P; Giolitti A; Giuliani S; Quartara L; Rotondaro L; Zappitelli S; Maggi CA
    Br J Pharmacol; 2011 Mar; 162(5):1202-12. PubMed ID: 21108627
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of the non-peptide B2 antagonist FR173657 on kinin-induced smooth muscle contraction and relaxation, vasoconstriction and prostaglandin release.
    Griesbacher T; Sametz W; Legat FJ; Diethart S; Hammer S; Juan H
    Br J Pharmacol; 1997 Jun; 121(3):469-76. PubMed ID: 9179388
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenesis at the human tachykinin NK(2) receptor to define the binding site of a novel class of antagonists.
    Meini S; Bellucci F; Catalani C; Cucchi P; Patacchini R; Rotondaro L; Altamura M; Giuliani S; Giolitti A; Maggi CA
    Eur J Pharmacol; 2004 Mar; 488(1-3):61-9. PubMed ID: 15044036
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 4. Discovery of novel frameworks mimicking the active conformation.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Nov; 41(23):4587-98. PubMed ID: 9804698
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New insights into the stereochemical requirements of the bradykinin B2 receptor antagonists binding.
    Lupala CS; Gomez-Gutierrez P; Perez JJ
    J Comput Aided Mol Des; 2016 Jan; 30(1):85-101. PubMed ID: 26697880
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Characterization of FR173657, a novel nonpeptide B2 antagonist: in vitro and in vivo studies.
    Inamura N; Asano M; Kayakiri H; Hatori C; Oku T; Nakahara K
    Can J Physiol Pharmacol; 1997 Jun; 75(6):622-8. PubMed ID: 9276139
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel class of orally active non-peptide bradykinin B2 receptor antagonists. 3. Discovering bioisosteres of the imidazo[1,2-a] pyridine moiety.
    Abe Y; Kayakiri H; Satoh S; Inoue T; Sawada Y; Inamura N; Asano M; Aramori I; Hatori C; Sawai H; Oku T; Tanaka H
    J Med Chem; 1998 Oct; 41(21):4062-79. PubMed ID: 9767643
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The identification of an orally active, nonpeptide bradykinin B2 receptor antagonist, FR173657.
    Asano M; Inamura N; Hatori C; Sawai H; Fujiwara T; Katayama A; Kayakiri H; Satoh S; Abe Y; Inoue T; Sawada Y; Nakahara K; Oku T; Okuhara M
    Br J Pharmacol; 1997 Feb; 120(4):617-24. PubMed ID: 9051299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Binding characteristics of [3H]-JSM10292: a new cell membrane-permeant non-peptide bradykinin B2 receptor antagonist.
    Faussner A; Schüssler S; Feierler J; Bermudez M; Pfeifer J; Schnatbaum K; Tradler T; Jochum M; Wolber G; Gibson C
    Br J Pharmacol; 2012 Oct; 167(4):839-53. PubMed ID: 22646218
    [TBL] [Abstract][Full Text] [Related]  

  • 18. LF16-0687 a novel non-peptide bradykinin B2 receptor antagonist reduces vasogenic brain edema from a focal lesion in rats.
    Schulz J; Plesnila N; Eriskat J; Stoffel M; Pruneau D; Baethmann A
    Acta Neurochir Suppl; 2000; 76():137-9. PubMed ID: 11449993
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative antagonist pharmacology at the native mouse bradykinin B2 receptor: radioligand binding and smooth muscle contractility studies.
    Meini S; Cucchi P; Bellucci F; Catalani C; Giuliani S; Santicioli P; Maggi CA
    Br J Pharmacol; 2007 Feb; 150(3):313-20. PubMed ID: 17179941
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dual antagonists of the bradykinin B1 and B2 receptors based on a postulated common pharmacophore from existing non-peptide antagonists.
    Morissette G; Bouthillier J; Marceau F
    Biol Chem; 2006 Feb; 387(2):189-94. PubMed ID: 16497151
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.